Table 1: Anthropometric and biochemical characteristics by groups.

VariablePAD group
Non-PAD group
Comparison between groups
P-value

Gender: male*,a82 80 0.603
Smokers*,a62 43 <0.001
DM*,a33 32 0.840
Obesity*,a20 22 0.665
AHT*,a61 48 0.024
Antihypertensive agentsa53 42 0.049
CAD*,a53 37 0.005
Age (years)**,b63 (56; 74)62 (57; 71)0.626
BMI (kg/m2)**,b25.82 (23.12; 29.07)25.73 (22.71; 29.34)0.896
Cholesterol (mg/dL)**,b194 (167; 230)191 (157; 223)0.139
TG (mg/dL)**,b113 (89; 140)104 (80; 139)0.028
HDL (mg/dL)**,b49 (42; 56)48 (41; 55)0.356
Statinsa75 72 0.549
Glycemia (mg/dL)**,b96 (86; 126)96 (86; 108)0.207
Diabetes durationa
 ≤5 years7 8 0.739
 5–10 years13 13 >0.999
 >10 years12 9 0.376
Diabetes treatmenta
 Oral hypoglycemic agent***8 10 0.542
 Insulin therapy17 17 >0.999
 Oral and Insulin therapy7 4 0.224
Creatinine (mg/dL)**,b0.90 (0.70; 1.00)0.90 (0.70; 1.00)0.094
Fibrinogen (mg/dL)**,b306 (249; 367)343 (310; 387)<0.001c
CRP (mg/dL)**,b0.70 (0.50; 0.90)0.90 (0.60; 1.00)0.816

% [95% CI]; **median (Q1; Q3), where Q1 = 25th percentile; Q3 = 75th percentile; ***biguanides or sulfonylurea; aP value associated with -test; bP-value associated with Mann-Whitney test; cnormal limits for both groups; DM: diabetes mellitus; AHT: arterial hypertension; CAD: coronary artery disease; BMI: body mass index; TG: triglycerides; HDL: high density lipoprotein; CRP: C-reactive protein.